Widely spaced alternative promoters, conserved between human and rodent, control expression of the Opitz syndrome gene MID1
- PMID: 12408967
Widely spaced alternative promoters, conserved between human and rodent, control expression of the Opitz syndrome gene MID1
Abstract
Mutations in the gene MID1 are responsible for the X-linked form of Opitz syndrome, a genetic disorder that primarily affects the development of midline structures. Several mRNA isoforms with variant 5' ends have been reported for MID1, suggesting the presence of alternative transcription initiation sites. However, the genomic organization and expression pattern of the heterogeneous MID1 5'-untranslated regions (UTRs), as well as the promoter regions regulating their transcription, have not been determined. We now report the characterization of alternative MID1 first exons and their associated promoters in human and other species. Multiple transcription initiation sites, dispersed over 250 kb on Xp22, were found to give rise to five MID1 isoforms in human that differed in their 5'-UTRs, but contained identical coding sequence. These alternative MID1 transcripts showed distinct expression patterns with the most 5' first exon being adipose-specific and another exon being placenta-selective, whereas other 5'-UTRs seemed to be ubiquitous. Consistent with the expression data, the putative promoter regions upstream of the variant first exons also varied in their strength and tissue specificity in transfection experiments. Similar to the human gene, heterogeneous Mid1 isoforms were also identified in mouse and rat by 5'-RACE, which revealed that three of the five alternative first exons isolated in human are also used in rodent. Comparison of MID1 promoter regions from several mammals indicated a high level of identity suggesting evolutionary conservation. Together, these results suggest that alternative promoters are important in the complex transcriptional regulation of MID1 expression in several species.
Similar articles
-
Alternative polyadenylation signals and promoters act in concert to control tissue-specific expression of the Opitz Syndrome gene MID1.BMC Mol Biol. 2007 Nov 15;8:105. doi: 10.1186/1471-2199-8-105. BMC Mol Biol. 2007. PMID: 18005432 Free PMC article.
-
FXY2/MID2, a gene related to the X-linked Opitz syndrome gene FXY/MID1, maps to Xq22 and encodes a FNIII domain-containing protein that associates with microtubules.Genomics. 1999 Dec 15;62(3):385-94. doi: 10.1006/geno.1999.6043. Genomics. 1999. PMID: 10644436
-
MID2, a homologue of the Opitz syndrome gene MID1: similarities in subcellular localization and differences in expression during development.Hum Mol Genet. 1999 Aug;8(8):1397-407. doi: 10.1093/hmg/8.8.1397. Hum Mol Genet. 1999. PMID: 10400986
-
Tissue specific glucocorticoid receptor expression, a role for alternative first exon usage?Biochem Pharmacol. 2006 Nov 30;72(11):1529-37. doi: 10.1016/j.bcp.2006.07.005. Epub 2006 Aug 22. Biochem Pharmacol. 2006. PMID: 16930562 Review.
-
The MID1/PP2A complex: a key to the pathogenesis of Opitz BBB/G syndrome.Bioessays. 2003 Apr;25(4):356-66. doi: 10.1002/bies.10256. Bioessays. 2003. PMID: 12655643 Review.
Cited by
-
Regulation of the MID1 protein function is fine-tuned by a complex pattern of alternative splicing.Hum Genet. 2004 May;114(6):541-52. doi: 10.1007/s00439-004-1114-x. Epub 2004 Mar 31. Hum Genet. 2004. PMID: 15057556
-
Increasing alternative promoter repertories is positively associated with differential expression and disease susceptibility.PLoS One. 2010 Mar 1;5(3):e9482. doi: 10.1371/journal.pone.0009482. PLoS One. 2010. PMID: 20208995 Free PMC article.
-
Widely variable endogenous retroviral methylation levels in human placenta.Nucleic Acids Res. 2007;35(14):4743-54. doi: 10.1093/nar/gkm455. Epub 2007 Jul 7. Nucleic Acids Res. 2007. PMID: 17617638 Free PMC article.
-
Reduced Mid1 Expression and Delayed Neuromotor Development in daDREAM Transgenic Mice.Front Mol Neurosci. 2012 May 3;5:58. doi: 10.3389/fnmol.2012.00058. eCollection 2012. Front Mol Neurosci. 2012. PMID: 22563308 Free PMC article.
-
An endogenous retroviral long terminal repeat is the dominant promoter for human beta1,3-galactosyltransferase 5 in the colon.Proc Natl Acad Sci U S A. 2003 Oct 28;100(22):12841-6. doi: 10.1073/pnas.2134464100. Epub 2003 Oct 8. Proc Natl Acad Sci U S A. 2003. PMID: 14534330 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases